(S (NP (DT The) (NML (NML (JJ human) (NN papillomavirus)) (-LRB- -LRB-) (NML (NN HPV)) (-RRB- -RRB-)) (NN vaccine)) (VP (VBZ is) (NP (DT the) (ADJP (RBS most) (JJ effective)) (NN way) (S (VP (TO to) (VP (VB prevent) (NP (ADJP (NP (NN HPV)) (HYPH -) (VBN related)) (NNS cancers))))))) (. .))
(S (S (VP (VBG Integrating) (NP (NML (NN provider) (NN vaccine)) (NN counseling)))) (VP (VBZ is) (ADJP (JJ crucial) (PP (IN to) (S (VP (VBG improving) (NP (NML (NNP HPV) (NN vaccine)) (NN completion) (NNS rates))))))) (. .))
(S (S (VP (VBG Automating) (NP (DT the) (NN counseling) (NN experience)) (PP (IN through) (NP (DT a) (JJ conversational) (NN agent))))) (VP (MD could) (VP (VB help) (S (VP (VP (VB improve) (NP (NNP HPV) (NN vaccine) (NN coverage))) (CC and) (VP (VB reduce) (NP (NP (DT the) (NN burden)) (PP (IN of) (NP (NN vaccine) (NN counseling)))) (PP (IN for) (NP (NNS providers)))))))) (. .))
(S (PP (IN In) (NP (DT a) (JJ previous) (NN study))) (, ,) (NP (PRP we)) (VP (VBD tested) (NP (NP (DT a) (JJ simulated) (JJ conversational) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBD provided) (NP (NNP HPV) (NN vaccine) (NN counseling)) (PP (IN for) (NP (NP (NNS parents)) (VP (VBG using) (NP (NP (DT the) (NNP Wizard)) (PP (IN of) (NP (NNP OZ) (NN protocol)))))))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ current) (NN study))) (, ,) (NP (PRP we)) (VP (VBD assessed) (NP (DT the) (JJ conversational) (NN agent)) (PP (IN among) (NP (JJ young) (NN college) (NNS adults) (PRN (-LRB- -LRB-) (S (NP (NN n)) (VP (SYM =) (NP (CD 24)))) (-RRB- -RRB-)))) (, ,) (NP (NP (DT a) (NN population)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB have) (VP (VBN missed) (NP (DT the) (NNP HPV) (NN vaccine)) (PP (IN during) (NP (PRP$ their) (NN adolescence))) (SBAR (WHADVP (WRB when)) (S (NP (NN vaccination)) (VP (VBZ is) (VP (VBN recommended)))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBN administered) (NP (NNS surveys)) (PP (PP (IN for) (NP (NML (NN system) (CC and) (NN voice)) (NN usability))) (, ,) (CC and) (PP (IN for) (NP (NP (NN health) (NNS beliefs)) (PP (VBG concerning) (NP (DT the) (NNP HPV) (NN vaccine))))))) (. .))
(S (S (NP (NNS Participants)) (VP (VBD perceived) (NP (DT the) (NN agent)) (S (VP (TO to) (VP (VB have) (NP (NP (JJ high) (NN usability)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (ADJP (RB slightly) (JJR better)) (CC or) (ADJP (JJ equivalent) (PP (IN to) (NP (JJ other) (NN voice))))) (S (ADJP (JJ interactive) (SBAR (S (VP (VBZ interfaces))))))))))))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBZ is) (NP (DT some) (NN evidence)) (SBAR (IN that) (S (NP (DT the) (NN agent)) (VP (VBD impacted) (NP (PRP$ their) (NNS beliefs)) (PP (VBG concerning) (NP (NP (DT the) (NNS harms)) (, ,) (NP (NN uncertainty)) (, ,) (CC and) (NP (NP (NN risk) (NNS denials)) (PP (IN for) (NP (DT the) (NNP HPV) (NN vaccine))))))))))) (. .))
(S (ADVP (RB Overall)) (, ,) (NP (DT this) (NN study)) (VP (VBZ demonstrates) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (JJ conversational) (NNS agents)))) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ impactful) (NN tool)) (PP (IN for) (NP (NML (NN health) (NN promotion)) (NNS endeavors)))))))) (. .))
